BioMarin’s achondroplasia drug gets nod for children of all ages
HQ Team October 21, 2023: The FDA cleared BioMarin Pharmaceuticals’s Voxzogo injection for treating achondroplasia, a common form of short-limbed dwarfism in children.
Drugs
Health
Pharma